• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/34

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

34 Cards in this Set

  • Front
  • Back
Definition
*IBD is used to describe two separate diseases, Ulcerative Colitis and Crohn's Disease
*Chronic inflammatory condition that affects small intestine, large intestine, or both
*Characterized by remissions and exacerbations
Incidence
1 million Americans suffer from IBD
Ulcerative Colitis U.C. any age but peaks at 15-25 and again 60-80 years old, both sexes equal risk
Crohn's any age but common 15-30 y.o., slightly higher incidence in women
Both high incidence in Jewish & upper middle class urban population
Risk Factors/Causes
*Extensive research done: etiology unknown
*Infectious process (virus, autoimmune)
*Autoimmune
*Food allergies
*Hereditary 15% 1st degree relative
*Psychosocial (stress or psychological factors
Pathophysiology:Ulcerative Colitis
*Inflammation is diffuse and involves only the mucosa and submucosa of the bowel w/ alternating periods of exacerbations and remissions
*Disease begins in rectum and spreads up colon in a continuous pattern
*Mucosa of colon is hyperemic (excessively reddened) and edematous.
Pathophysiology:Ulcerative Colitis
*Abscesses develop and break through the intestinal glands into the submucosa leaving ulcerations.
*Mucosal epithelium is destroyed causing bleeding and diarrhea.
*Lose fluids and electrolytes due to decreased mucosal surface for absorption.
Pathophysiology:Ulcerative Colitis
*Breakdown of cells leads to protein loss.
*Areas of inflammed mucus develop pseudopolyps the mucosa becomes thickened and the colon shortens.
Manifestations: Ulcerative Colitis
Acute crisis or chronic disorder
*Abdominal Pain
-Mild (cramps)
-Severe (abdominal pain - perforation - death)
*Bloody diarrhea (mucous) Classic sign
-Mild: 1-2 semi formed stools w/ small amts of blood.
-Moderate: 4-5 stools/day
-Severe: 10-20 stools/day that contains mucus and blood
Manifestations: Ulcerative Colitis
*Additional: Dehydration, fever, weight loss, anemia, tachycardia, and dehydration
*Intestinal:
-Hemorrhage major complication
-Strictures narrowing of area
-Toxic megacolon 5% of patients boardlike abdomen
-Colonic Dilation
-Perforation (usually occurs with toxic megacolon)
Manifestations: Ulcerative Colitis
*Extraintestinal:
-1/3 have at least one manifestation (may be only presenting sx)
Arthritis
Finger Clubbing
Stiff back
Skin rashes
ulcers of the mouth
liver disease
peptic ulcer disease
Classification: Ulcerative Colitis
Mild - gradual onset mild cramps, frequent stools, small amount rectal bleeding
Moderate - 4-5 loose, bloody stools pain keeps them from sleeping, low grade fever, extraintestinal symptoms
Severe - explosive diarrhea, lots of urgency, increased fever, wt. loss, dehydration, low B/P, increased pulse
Intractable - 30-50 bowel movements/day
Diagnostic Studies: Recall
*Colonoscopy visualize colon & inflammation
*New virtual colonoscopy
*Sigmoidoscopy
*Barium Enema
*CBC
*Stool for blood and C&s
Treatment: Medical
**Goals**
Rest Bowel
Reduce inflammation
Reduce immune response
Prevent complications
Treatment: Nutritional
**Goals**
Provide adequate nutrition without exacerbating symptoms
Correct metabolic and nutritional deficits
Replace fluid and electrolyte losses
Prevent weight loss
Treatment: Nutritional
Acute phase: NPO
IV fluids and electrolyte replacement
May need TPN (daily weights)
When permitted start clear liquids, then full liquids, then high calorie, high protein, low residue diet with vitamin and iron supplements
Treatment: Pharmacological
*Antimicrobial (flagyl)
*Corticosteroids (solumedrol, prednisone)
*Anticholinergic (banthine) decrease GI motility and relax smooth muscles from spasms
*5-Aminosalicylates (azulfadine, rowasa (topical enema, steroid enema reduce inflammation @ the site))
Treatment: Pharmacological
*Sedatives (valium, dalmane) reduce anxiety
*Antidiarrheal (Lomotil)
*Immunosuppressives (Imuran) suppress immune response
*Immunomodulators (Remicade) IV
*Hematinics & Vitamins (Iron, B12, zinc, folate)
Reasons for Surgical Tx.
*Failure to respond to therapy
*Exacerbations are frequent and debilitating
*Massive bleeding, strictures, obstruction.
*Dysplasia (pre-cancerous cell)
*Carcinoma
Treatment: Surgical
*Total Proctocolectomy with permanent ileostomy
*Total proctocolectomy with continent ileostomy. (koch pouch)
*Total colectomy and ileal reservoir (2 surgeries)
Sequelae/Complications of U.C.
*GI Bleeding
*Abscess, fissure (cracks in bowel), fistula
*Fluid and electrolyte imbalance
*Toxic megacolon
*Anemia (from GI bleeding)
*Intestinal Obstruction
*Colon Cancer (10+ years with ulcerative colitis increases risk of colon cancer)
Pathophysiology: Crohn's Disease
*Inflammation of segments of GI tract
*Any part of colon, most often terminal ileum and jejunum.
*Inflammation involves all 4 layers of bowel wall
*Areas of inflammation are discontinuous
Pathophysiology: Crohn's Disease
*Ulcerations deep and longitudinal penetrate between islands of edematous mucosa causing classic COBBLESTONE APPEARANCE.
*Bowel wall thickens and the lumen narrows leads to stricture development.
*Abscesses and fistula tracts develop (ex: bowel-bladder Risk for infection)
Incidence/Risk Factors
*Cause unknown (? genetic, environmental)
*Most often between ages of 15-30.
*In older adults morbidity and mortality increases.
*Slightly higher incidence in females.
*Jewish, upper middle class urban population
*Lower incidence than Ulcerative Colitis
Manifestations: Crohn's Disease
*Onset insidious
*Abdominal pain in RLQ relieved by defecation
**Diarrhea usually non-bloody** MAJOR difference between U.C. and Crohn's disease
*Systemic (fever, fatigue, wt. loss)
Manifestations: Crohn's Disease
*Chronic Disorder
*Unpredictable periods of recurrence & remission
*Attacks are intermittent
*Diarrhea and pain subside spontaneously
Diagnostic Studies
*History and Physical
*Barium Studies
*Laboratory studies
*Endoscopy w/ biopsy
Treatment: Medical
**Goals**
-Control inflammation
-Relieve manifestations
-Correct metabolic and nutritional problems
-Promote healing
Treatment: Nutritional
*High calorie, high vitamin, high protein, low residue, milk free
*vitamin deficiencies d/t lack of absorption (vit. B12)
*TPN daily weights
Treatment: Pharmacological
*Antidiarrheals (lomotil)
*Sulfasalazine (azulfidine) most popular drug
*Corticosteroids (prednisone)
*Immunosuppressives (Imuran) lots of side effects
Pharmacological
*Infliximab (Remicade)
*Metronidazole (Flagyl)S/E metallic taste in mouth (give hard candy) no alcohol w/ flagyl 24-48 hrs after discontinuing the drug. If alcohol taken violently ill with vomiting
*Fish oil (helps prevent reoccurrences of inflammation)
Treatment: Surgical
*Severe symptoms
*Unresponsive to therapy
*Life threatening complications
*Conservative intestinal resection with anastomosis of healthy bowel
75% pts require surgery - 20 yrs
90% pts require surgery - 30 yrs
Sequelae/Complications of Crohn's
*Perianal abscess
*Fistulas
*Fissures
*Obstruction
*Pancreatitis
*Carcinoma - increased risk of colon cancer and gallstones
*Gallstones
Nursing Care Plan
**Teaching**
*diet and rest
*Perianal care (lots of diarrhea, hemorrhoids)
*Medications
*Symptoms of recurrence of disease
*When to seek medical care
*Diversional activities
Current Trends/Research
*Inflammatory Bowel Disease Act (2004)
-Expand and enhance IBD research NIH
-Establish an IBD prevention and epidemiology program at CDC
-Require federal studies to identify barriers that IBD patients encounter when seeking insurance coverage and applying for Social Security Disability
Current Trends/Research
*Article from RN magazine
*Crohn's and Colitis Foundation of America
*National Institute of Diabetes & Digestive & Kidney Diseases
www.niddk.nih.gov